Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus Suppresses DMH-Induced Procarcinogenic Fecal Enzymes and Preneoplastic Aberrant Crypt Foci in Early Colon Carcinogenesis in Sprague Dawley Rats
暂无分享,去创建一个
[1] M. Glei,et al. Effects of synbiotic fermentation products on primary chemoprevention in human colon cells. , 2012, The Journal of nutritional biochemistry.
[2] A. Jemal,et al. Global Cancer Statistics , 2011 .
[3] D. Ma,et al. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. , 2009, The Journal of nutritional biochemistry.
[4] G. Shukla,et al. Effect of Lactobacillus casei as a Probiotic on Modulation of Giardiasis , 2008, Digestive Diseases and Sciences.
[5] D. Cunningham,et al. Adjuvant therapy in colon cancer--what, when and how? , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] J. Ashton,et al. Stability of β-glucosidase Activity Produced by Bifidobacterium and Lactobacillus spp. in Fermented Soymilk During Processing and Storage , 2006 .
[7] S. B. Garcia,et al. Exhaustive physical exercise increases the number of colonic preneoplastic lesions in untrained rats treated with a chemical carcinogen. , 2004, Cancer letters.
[8] M. L. Cross. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. , 2002, FEMS immunology and medical microbiology.
[9] W. Walker,et al. Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. , 2002, Annual review of nutrition.
[10] K. Uchida,et al. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. , 2001, Cancer research.
[11] G. Rechkemmer,et al. Protective role of probiotics and prebiotics in colon cancer. , 2001, The American journal of clinical nutrition.
[12] P. Marteau,et al. Protection from gastrointestinal diseases with the use of probiotics. , 2001, The American journal of clinical nutrition.
[13] Sang-Myeong Lee,et al. Inhibitory Effects of Lactic Acid Bacteria (LAB) on the Azoxymethane-induced Colonic Preneoplastic Lesions , 2000 .
[14] G. Beecher,et al. Isoflavones in retail and institutional soy foods. , 1999, Journal of agricultural and food chemistry.
[15] Glenn R. Gibson,et al. Prebiotics, probiotics and human gut microbiology , 1999 .
[16] G. Schaafsma,et al. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans , 1998, European Journal of Clinical Nutrition.
[17] K. Kataoka,et al. Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon. , 1997, Biochemical and biophysical research communications.
[18] I. Rowland,et al. Lactobacillus- and bifidobacterium-mediated antigenotoxicity in the colon of rats. , 1996, Nutrition and cancer.
[19] B. Goldin,et al. The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat. , 1996, Nutrition and cancer.
[20] F. Berrino,et al. Comparisons of colon–cancer survival among european countries: The eurocare study , 1995, International journal of cancer.
[21] R P Bird,et al. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. , 1995, Cancer letters.
[22] R. Korpela,et al. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. , 1994, The Journal of nutrition.
[23] O. Meyer,et al. Influence of a dietary fiber on development of dimethylhydrazine-induced aberrant crypt foci and colon tumor incidence in Wistar rats. , 1994, Nutrition and cancer.
[24] Y. Benno,et al. Impact of Bifidobacterium longum on Human Fecal Microflora , 1992, Microbiology and immunology.
[25] Y. Kubota. [Fecal intestinal flora in patients with colon adenoma and colon cancer]. , 1990, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.
[26] B. Goldin,et al. Intestinal microflora: metabolism of drugs and carcinogens. , 1990, Annals of medicine.
[27] Bruce Wr,et al. Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. , 1989 .
[28] W. R. Bruce,et al. Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. , 1989, Cancer surveys.
[29] R P Bird,et al. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. , 1987, Cancer letters.
[30] Y. Ohnishi,et al. Metabolic Activation of 1–Nitropyrene and 1, 6–Dinitropyrene by Nitroreductases from Bacteroides fragilis and Distribution of Nitroreductase Activity in Rats , 1986, Microbiology and immunology.
[31] D. W. Day,et al. The adenoma-carcinoma sequence. , 1984, Scandinavian journal of gastroenterology. Supplement.
[32] V. Wright,et al. Effect of klebsiella capsular antisera on lymphocytes from patients with ankylosing spondylitis. , 1981, Journal of medical microbiology.
[33] B. Goldin,et al. The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. , 1976, Journal of the National Cancer Institute.
[34] J. Weisburger,et al. Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. , 1975, Cancer research.
[35] B. Drasar,et al. Intestinal bacteria and the hydrolysis of glycosidic bonds. , 1971, Journal of medical microbiology.
[36] R. Kato,et al. Studies on the mechanism of nitro reduction by rat liver. , 1969, Molecular pharmacology.
[37] J. Gillette,et al. Mechanism of p-nitrobenzoate reduction in liver: the possible role oc cytochrome P-450 in liver microsomes. , 1968, Molecular pharmacology.
[38] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.